Welcome to our dedicated page for Odysight.ai SEC filings (Ticker: ODYS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Odysight.ai Inc. (NASDAQ: ODYS) SEC filings page on Stock Titan provides access to the company’s regulatory documents as filed with the U.S. Securities and Exchange Commission. Odysight.ai is a Nevada corporation whose common stock is listed on the Nasdaq Capital Market under the symbol ODYS, and its filings offer detailed information on its AI-powered visual sensing, Predictive Maintenance (PdM), and Condition-Based Monitoring (CBM) business.
Among the key filings are Form 10-K annual reports and related documents, which, as referenced in company press releases, discuss Odysight.ai’s operations, risk factors, and financial statements. Form 8-K current reports, such as those dated August 13, 2025 and November 13, 2025, furnish press releases announcing financial results and business updates, while other 8-K filings cover events like updated investor presentations and executive appointments.
Odysight.ai has also filed a Form S-1 registration statement related to the resale of common stock by selling stockholders, which describes the company’s business overview, corporate history, subsidiaries in Israel and Europe, and its focus on visual-based PdM and CBM solutions. A DEF 14A definitive proxy statement outlines matters for stockholder votes, including director elections, executive compensation advisory votes, share incentive plan amendments, and auditor ratification.
On Stock Titan, users can review these filings in one place and use AI-powered summaries to understand lengthy documents such as 10-Ks, S-1 registration statements, and proxy materials. The platform also surfaces real-time updates from EDGAR, making it easier to track new Odysight.ai filings, interpret financial and operational disclosures, and follow governance items presented to shareholders.
Odysight.ai Inc. (ODYS) has a large concentrated shareholder base, with M. Arkin (1999) Ltd. and its sole shareholder, Moshe Arkin, disclosing significant beneficial ownership. As of August 20, 2026, Arkin Ltd. beneficially owned 4,135,724 shares of common stock, representing 20.4% of the outstanding shares. On the same date, Moshe Arkin beneficially owned 6,770,562 shares, representing 33.34% of the outstanding shares, including the shares held by Arkin Ltd. and by Phoenix Insurance Company Ltd. on his behalf. The disclosure details a series of primary and secondary share purchases, warrant exercises and option grants since 2020, including a recent purchase on August 20, 2026 of 1,125,000 shares from Odysight.ai for $3,600,000. The investors state they may increase or decrease their holdings over time, depending on Odysight.ai’s business, share price and market conditions.
Odysight.ai Inc. (ODYS) is the subject of an amended Schedule 13G/A in which two Israeli management companies, Kranot Hishtalmut Le Morim Ve Gananot Hevera Menahelet Ltd. and Kranot Hishtalmut Le Morim Tichoniim Hevera Menahelet Ltd., report aggregate beneficial ownership of 1,996,737 Ordinary Shares of common stock. This represents 9.86% of Odysight.ai’s Ordinary Shares, based on 20,244,405 shares outstanding as of August 25, 2026. As of August 20, 2026, 1,506,737 shares (7.44%) are held by mutual funds managed by the first entity and 490,000 shares (2.42%) by provident funds managed by the second. The reporting entities state that the shares are held for the benefit of members of education funds, that they operate under independent management, and they expressly disclaim beneficial ownership of the securities.
Odysight.ai Inc. (ODYS) director Benad Goldwasser reported a purchase of 46,875 shares of common stock made by his spouse on August 20, 2026 in the company’s underwritten public offering at an offering price of $3.20 per share. These shares are reported as indirectly held, and Goldwasser disclaims beneficial ownership of his spouse’s holdings for Section 16 and other purposes. A separate line reflects 118,941 directly held shares included for informational purposes only, with no transaction effected for that position. The Rule 10b5-1 checkbox is not marked, so the reported purchase is not affirmed as made under a trading plan.
Odysight.ai Inc. (ODYS) director Zeev Vurembrand reported purchasing 31,250 shares of common stock on August 20, 2026. The shares were acquired in Odysight.ai Inc.’s underwritten public offering at an offering price of $3.20 per share, bringing his directly held common stock to 46,250 shares.
Odysight.ai Inc. (ODYS) reported that director and ten percent owner Moshe Arkin, through entity M.Arkin (1999) Ltd., purchased 1,125,000 shares of common stock on August 20, 2026 in an underwritten public offering at $3.20 per share. Following this transaction, that entity held 4,084,143 shares indirectly. A separate indirect holding of 2,624,838 shares through Phoenix Insurance Company Ltd. was disclosed for informational purposes only, with no transaction effected in these shares.
Odysight.ai Inc. (ODYS) entered into an Underwriting Agreement with Roth Capital Partners, LLC for a firm commitment underwritten public offering of 3,437,500 shares of common stock at a public offering price of $3.20 per share. This implies expected gross proceeds of $11 million before underwriting discounts, commissions, and other offering expenses. Odysight.ai intends to use the net proceeds for research and development, sales and marketing including scaling commercial operations, and for working capital and other general corporate purposes.
The underwriters have a 30-day option to purchase up to an additional 515,625 shares, representing 15% of the Firm Shares, at the same public offering price less underwriting discounts and commissions. The Representative will receive 6.5% of the gross proceeds as underwriting discounts and commissions, and up to $75,000 as expense reimbursement. Odysight.ai, its directors, and executive officers agreed to a 45-day lock-up, restricting sales or transfers of common stock without the Representative’s consent. The shares are being issued under an effective Form S-3 shelf registration and a final prospectus supplement. Separately, Odysight.ai terminated its prior at-the-market Sales Agreement and related prospectus for up to $20,000,000 of common stock, and disclosed that no sales were made under that program.
Odysight.ai Inc. (symbol ODYS) is conducting a firm-commitment underwritten public offering of 3,437,500 shares of common stock at $3.20 per share. Gross proceeds are $11.0 million, with estimated net proceeds of about $9.9 million (or $11.4 million if the underwriters’ 30‑day option to buy up to 515,625 additional shares is fully exercised).
Common stock outstanding will increase from 16,806,905 to 20,244,405 shares (or 20,760,030 with the option). Certain directors, including chairman Benad Goldwasser, Mori Arkin and Zeev Vurembrand, have agreed to purchase an aggregate of 1,203,125 shares in this offering. The underwriter, Roth Capital Partners, receives a 6.5% discount.
The company expects net proceeds to be used for research and development, sales and marketing (including scaling commercial operations), and working capital and general corporate purposes. The offering increases as‑adjusted net tangible book value from $1.04 to $1.35 per share as of June 30, 2026, implying immediate dilution of $1.85 per share to new investors. Odysight.ai highlights significant geopolitical and security risks related to its Israel-based operations, including ongoing regional conflicts.
Odysight.ai Inc. (ODYS) announced the pricing of a firm commitment underwritten public offering of 3,437,500 shares of its common stock at $3.20 per share, for expected gross proceeds of $11 million before underwriting discounts, commissions and expenses. All shares are being sold by the company.
The company granted Roth Capital Partners a 30-day option to purchase up to 515,625 additional shares, equal to 15% of the base offering. Net proceeds are intended for research and development, sales and marketing to scale commercial operations, and for working capital and other general corporate purposes. The offering is expected to close on or about August 21, 2026, subject to customary closing conditions, and is being conducted under an effective shelf registration statement on Form S-3.
Odysight.ai Inc. (ODYS) plans a firm-commitment underwritten public offering of its common stock under an effective $200,000,000 Form S-3 shelf registration. The company’s shares trade on both Nasdaq and the Tel Aviv Stock Exchange under the symbol ODYS.
Net proceeds are expected to be used for research and development, sales and marketing (including scaling commercial operations), and general corporate and working-capital purposes, pending investment in short-term, high-quality instruments. Odysight.ai is a smaller reporting company focused on AI-driven visual monitoring solutions for predictive maintenance and condition-based monitoring across aviation, industrial, automotive and defense applications.
As of August 19, 2026, common shares outstanding were 16,806,905, with additional shares issuable under stock options and equity plans, so new investors face potential dilution from both this offering and existing equity awards. The company highlights risks from future equity financings, dual listing-driven price volatility, absence of dividends, and significant geopolitical and security risks tied to its Israel-based operations.
Odysight.ai Inc. reported first-half 2026 revenues of $0.5 million, down from $2.4 million a year earlier, reflecting prior-year revenue from a Fortune 500 medical customer and the timing of order execution. Gross profit was $0.2 million, and operating expenses rose slightly to $10.0 million, driven by expanded global sales and marketing and FX effects. Net loss widened to $9.5 million from $8.3 million.
Backlog was $14.1 million as of June 30, 2026 and approximately $16.45 million as of the release date, and the company ended the period with about $17.6 million in cash and no debt. Management highlights new purchase orders from Boeing, Elbit Systems (on behalf of the Israeli Ministry of Defense), and Honeywell Aerospace, as well as U.S. test flights on a UH-60 Black Hawk and a CRADA with the U.S. Navy’s NAWCAD. The company states that revenues are expected to be weighted toward the second half of 2026 as existing orders convert into deliveries.